$Forte Biosciences (FBRX.US)$On my top watchlist. News/update on their R&D on 3rd December 2024, Phase 1 top-line result by the second quarter of 2025. They have cash available which will sustain the company operations for 12 months (exclude the recent oversubscribed private placement 53mil)
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Forte Biosciences Stock Forum
News/update on their R&D on 3rd December 2024, Phase 1 top-line result by the second quarter of 2025. They have cash available which will sustain the company operations for 12 months (exclude the recent oversubscribed private placement 53mil)
No comment yet